: 1
That number is not a typographical error
The experience gets me contemplating the degree to which we have to quarterback our own health
The iron chelator DFO has been shown to decrease ROS production, mitigate hemoglobin-induced neurotoxicity, reduce brain edema, and enhance functional outcomes in both in vivo and in vitro models of CH ( 3.6 Traumatic brain injury Traumatic Brain Injury (TBI) is followed by a cascade of secondary injuries, including the release of excitatory neurotransmitters and Fe 2+ , OS, LP, and the accumulation of ROS, all of which induce ferroptosis ( Additionally, miR-212-5p regulates prostaglandin-endoperoxide synthase-2 to reduce ferroptosis-induced neuronal death ( 3.7 Spinal cord injuries Spinal cord injuries (SCI), known for causing severe disability and mortality, present significant medical challenges worldwide
10% excreted unchanged by the kidney hepatic dysfunction Glimepiride: (Amaryl) monotherapy -- once a day administration or in combination with insulin most potent -- lowest dose of the sulfonylureas long duration of action: half-life = 5 hours hepatic metabolism: complete to inactive products Secondary Failure and Tachyphylaxis to Sulfonylureas: Treatment failures occur Possibly due to pancreatic B cell refractoriness or to loss of dietary compliance Combination of sulfonylureas and insulin would appear justified only in the presence of severe insulin resistance Biguanides Metformin: (Glucophage) Proposed Mechanism of Action: glycolysis stimulation-- increased glucose removal from blood decreased hepatic gluconeogenesis decreased glucose absorption rate from the GI tract reduced plasma glucagon in patients with refractory obesity and insulin resistance Advantages: does not cause hypoglycemia does not increased weight May be used in combination with sulfonylureas when sulfonylurea monotherapy is not effective Toxic/adverse effects: most common -- gastrointestinal (20% frequency) anorexia, nausea, vomiting, diarrhea dose-related usually occurs upon initiation of therapy -- often transient in effect Decreased vitamin B12 absorption
In terms of the effects of tesamorelin on fasting glucose, fasting insulin, and 2 hour glucose on oral glucose tolerance, there were no noticeable differences detected in comparison to the placebo group [3]
